ada glp 1 recommendations Independent Nurse - GLP-1 and GIP/GLP-1 receptor agonists for type 2 diabetes ADA Recommends SGLT2 Inhibitors and

Wegovy (semaglutide) injection prescribing information

Lipodystrophy and nodule formation Subcutaneous nodules can form after GLP-1 injections, particularly with longer-acting formulations

One study presented cases of obstetric complications without statistical analyses, but found comparable rates of pregnancy loss, a decreased rate of preterm births, and an increased number of elective terminations following exposure to a GLP-1 RA (Dao et al

Younes ST, Maeda KJ, Sasser XJ, Michael X, Ryan J, Montgomery GVS

Hypothyroidism, vitamin D deficiency, inflammatory myopathies, fibromyalgia, and other musculoskeletal conditions may coincidentally present during GLP-1 therapy

Weve known for some time from animal studies that GLP-1 receptor agonists reduce alcohol intake and motivation to consume alcohol, shared Christian Hendershot, director of clinical research at the University of Southern California Institute for Addiction Science, in an article